Kymera Therapeutics Announces Series A to Advance Novel Therapeutic Modality and Develop Innovative Therapies

Company pioneers a novel integrated drug discovery platform to advance targeted protein degradation CAMBRIDGE, Mass., Oct. 30, 2017 -- (Healthcare Sales & Marketing Network) -- Kymera Therapeutics LLC today announced a $30M Series A Financing round to ... Biopharmaceuticals, Venture Capital, Personnel Kymera Therapeutics
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news